PT - JOURNAL ARTICLE AU - Niu, Huicong AU - Wang, Yong AU - Yang, Ning AU - Chu, Min AU - Mao, Xueyu AU - Wang, Daosheng AU - Zhao, Jing TI - Elevated remnant cholesterol improves prognosis of patients with ischemic stroke and malnutrition: a cohort-based study AID - 10.1101/2024.07.31.24311324 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.31.24311324 4099 - http://medrxiv.org/content/early/2024/08/02/2024.07.31.24311324.short 4100 - http://medrxiv.org/content/early/2024/08/02/2024.07.31.24311324.full AB - Background Aggressive lipid-lowering therapy is recommended for patients with ischemic stroke; however, lipid paradox has been reported in several clinical studies. The mechanism of lipid paradox remains uncertain, and nutrition maybe one explanation. In this prospective cohort study, we explored the associations between baseline remnant cholesterol (RC) concentrations and clinical outcomes in patients with ischemic stroke, stratified by nutritional status.Materials and Methods A total of 5257 patients with ischemic stroke were recruited for analysis. The Controlling Nutritional Status (CONUT) score was utilized to investigate the risk of malnutrition. Individuals were classified into 4 groups based on their CONUT score. Poor outcomes and all-cause mortality were compared among patients with varied nutritional status and RC levels.Results Patients with moderate-severe malnutrition had the highest incidences of in-hospital complications, including pulmonary infection, renal dysfunction, and hemorrhagic transformation, and the highest rates of poor outcomes (61.3%, P<0.001) and all-cause mortality (32.8%, P < 0.001) during the 3-month follow-up period. Baseline higher RC level was an independent protective factor of adverse clinical outcomes for patients with any degree of malnutrition, which was not observed in patients without malnutrition. In addition, compared with the moderate-severe malnourished with RC <0.471 mmol/L, the adjusted ORs for poor outcomes and all-cause mortality were 0.805 (0.450–1.438) and 0.898 (0.502-1.607) for participants with 0.471-0.632 mmol/L, 0.259 (0.095-0.704) and 0.222 (0.061-0.810) for 0.633-0.868 mmol/L, and 0.160 (0.037–0.689) and 0.202 (0.042-0.967) for ≥ 0.869 mmol/L, prospectively.Conclusion Lipid paradox was only observed in the malnourished patients with ischemic stroke. Strict lipid reduction therapy is still recommended for patients with ischemic stroke and good nutritional status. However, when treating patients at any risk of malnutrition, the improvement of nutritional status may be more crucial than aggressive lipid control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Natural Science Foundation of China grants/awards (82173646 and 81973157), and Fundamental Medical Project of Minhang Hospital of Fudan University Project Foundation (Grant Nos 2023MHBJ02).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:he study was approved by the Institutional Ethics Committee of Minhang Hospital of Fudan University and complied with the Declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData available within the article or its supplementary materials.LDL-Clow-density lipoprotein cholesterolRCremnant cholesterolVLDLvery low-density lipoproteinIDLintermediate-density lipoproteinCOUNTControlling Nutritional StatusmRSmodified Rankin ScaleTCtotal cholesterolTGtriglycerideNIHSSNational Institutes of Health Stroke ScaleLAAlarge-artery atherosclerosisCEcardioembolismSAOsmall-vessel occlusionTOASTTrial of ORG 10172 in Acute Stroke TreatmentHDL-Chigh-density lipoprotein cholesteroleGFRestimated glomerular filtration rateRCSsrestricted cubic splines.RMBChinese Yuan RenminbiORodds ratio.CIconfidence interval.